Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phathom Pharmaceuticals

3.14
+0.850037.12%
Post-market: 3.240.1000+3.18%19:59 EDT
Volume:12.64M
Turnover:41.67M
Market Cap:218.70M
PE:-0.60
High:3.78
Open:2.33
Low:2.33
Close:2.29
Loading ...

Craig-Hallum Reaffirms Their Buy Rating on Phathom Pharmaceuticals (PHAT)

TIPRANKS
·
06 Mar

Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025

GlobeNewswire
·
24 Feb

Cantor Fitzgerald Initiates Coverage on Phathom Pharmaceuticals With Overweight Rating, $23 Price Target

MT Newswires Live
·
14 Feb

Phathom Pharmaceuticals (PHAT) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
10 Feb

Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference

GlobeNewswire
·
29 Jan

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT): Are Analysts Optimistic?

Simply Wall St.
·
19 Jan

Phathom Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham

Dow Jones
·
10 Jan

Insider Sellers Might Regret Selling Phathom Pharmaceuticals Shares at a Lower Price Than Current Market Value

Simply Wall St.
·
14 Dec 2024

Do You Believe in the Growth Potential of Phathom Pharmaceuticals (PHAT)?

Insider Monkey
·
12 Dec 2024

Craig-Hallum Remains a Buy on Phathom Pharmaceuticals (PHAT)

TIPRANKS
·
12 Dec 2024

Phathom Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham

Dow Jones
·
12 Dec 2024

Phathom Pharmaceuticals Files US FDA Petition to Seek Voquezna Exclusivity Period

MT Newswires Live
·
11 Dec 2024

BRIEF-Phathom Pharmaceuticals Submits Citizen Petition To FDA

Reuters
·
11 Dec 2024

Phathom Pharmaceuticals submits Citizen Petition to FDA

TIPRANKS
·
11 Dec 2024

Phathom Pharmaceuticals Inc: Exclusivity Period Is Until May 3, 2032

THOMSON REUTERS
·
11 Dec 2024

Phathom: Petition Requests Correction of Orange Book Listings for Voquezna 10 Mg,20 Mg Tablets to Accurately Reflect 10-Year Nce Exclusivity Period

THOMSON REUTERS
·
11 Dec 2024

Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for Voquezna® (Vonoprazan) Tablets

THOMSON REUTERS
·
11 Dec 2024

Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets

GlobeNewswire
·
11 Dec 2024

Down -54.05% in 4 Weeks, Here's Why Phathom Pharmaceuticals (PHAT) Looks Ripe for a Turnaround

Zacks
·
06 Dec 2024

Phathom Pharmaceuticals Inc : Jefferies Cuts Target Price to $17 From $20

THOMSON REUTERS
·
05 Dec 2024